AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32074684 — intervention group
Group type: COMPARATOR
Intervention: Mosapride group (Mosapride citrate tablets 5 mg 3 times per day for 2 weeks)
Number of subjects: 323
Study 32074684 — intervention group
Group type: EXPERIMENTAL
Intervention: Combizym(®) group (Combizym tablets 244 mg 3 times per day for 2 weeks)
Number of subjects: 323
Study 32074684 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined treatment group (both drugs at same doses for 2 weeks)
Number of subjects: 323
Study 36127661 — intervention group
Group type: COMPARATOR
Intervention: Bumetanide plus placebo
Number of subjects: 32
Study 33629816 — intervention group
Group type: EXPERIMENTAL
Intervention: Talking With Voices intervention
Number of subjects: 50
Study 32446770 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical Exploration And Discovery (SEAD) program
Number of subjects: 62
Study 32446770 — intervention group
Group type: COMPARATOR
Intervention: Control group (instruction manual only)
Number of subjects: 62
Study 35105521 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluorouracil/leucovorin + oxaliplatin (FOLFOX) or irinotecan (FOLFIRI) plus bevacizumab, cetuximab or both
Number of subjects: 1345
Study 35105521 — intervention group
Group type: COMPARATOR
Intervention: Age ≥ 70
Number of subjects: 1345
Study 35105521 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of comorbidities
Number of subjects: 1345
Study 35105521 — intervention group
Group type: EXPERIMENTAL
Intervention: Age and comorbidities
Number of subjects: 1345
Study 33872182 — intervention group
Group type: EXPERIMENTAL
Intervention: Zemedy app (CBT program)
Number of subjects: 121
Study 33872182 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control
Number of subjects: 121
Study 32807229 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrative medicine rehabilitation (IMR) with usual rehabilitation (UR)
Number of subjects: 80
Study 32807229 — intervention group
Group type: COMPARATOR
Intervention: Usual rehabilitation (UR)
Number of subjects: 80
Study 36094054 — intervention group
Group type: EXPERIMENTAL
Intervention: Honey-rich energy drink (BeeBad EnegyDrink®, Parodi Group, Italy)
Number of subjects: 15
Study 36094054 — intervention group
Group type: COMPARATOR
Intervention: Popular energy drink with free sugars
Number of subjects: 15
Study 33263957 — intervention group
Group type: EXPERIMENTAL
Intervention: Early detection of prostate cancer through prostate specific antigen screening
Number of subjects: 0
Study 33263957 — intervention group
Group type: COMPARATOR
Intervention: Prostate specific antigen screening
Number of subjects: 0
Study 35745123 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional supplementation and education
Number of subjects: 29
Study 35745123 — intervention group
Group type: COMPARATOR
Intervention: Standard care for wound treatment
Number of subjects: 29
Study 32534040 — intervention group
Group type: EXPERIMENTAL
Intervention: Resveratrol (250 mg/day)
Number of subjects: 25
Study 32534040 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study 33569986 — intervention group
Group type: EXPERIMENTAL
Intervention: FTD/TPI plus bevacizumab
Number of subjects: 490
Study 33569986 — intervention group
Group type: COMPARATOR
Intervention: FTD/TPI monotherapy
Number of subjects: 490
Study 36355369 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher protein formula
Number of subjects: 1678
Study 36355369 — intervention group
Group type: COMPARATOR
Intervention: Lower protein formula
Number of subjects: 1678
Study 36355369 — intervention group
Group type: COMPARATOR
Intervention: Breastfed reference group
Number of subjects: 1678
Study 33076983 — intervention group
Group type: EXPERIMENTAL
Intervention: Multidomain intervention (MI)
Number of subjects: 67
Study 33076983 — intervention group
Group type: COMPARATOR
Intervention: No MI group (Control)
Number of subjects: 67
Study 32866688 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel camera system
Number of subjects: 16
Study 33168092 — intervention group
Group type: EXPERIMENTAL
Intervention: Sub-optimal infant and young child feeding practices
Number of subjects: 418
Study 33168092 — intervention group
Group type: EXPERIMENTAL
Intervention: Husband being a government employee
Number of subjects: 418
Study 33168092 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower household income
Number of subjects: 418
Study 33168092 — intervention group
Group type: EXPERIMENTAL
Intervention: Not attending antenatal care
Number of subjects: 418
Study 33168092 — intervention group
Group type: EXPERIMENTAL
Intervention: Child age 0-5 months
Number of subjects: 418
Study 33168092 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative attitude towards infant and young child feeding practices
Number of subjects: 418
Study 33168092 — intervention group
Group type: EXPERIMENTAL
Intervention: Number of children 3-4
Number of subjects: 418
Study 33548936 — intervention group
Group type: EXPERIMENTAL
Intervention: Lavender oil
Number of subjects: 49
Study 33548936 — intervention group
Group type: COMPARATOR
Intervention: Placebo (coconut oil)
Number of subjects: 49
Study 33548936 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall cohort (preoperative vs postoperative)
Number of subjects: 49
Study 32482095 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 g protein post-exercise
Number of subjects: 18
Study 32482095 — intervention group
Group type: COMPARATOR
Intervention: 20 g protein post-exercise
Number of subjects: 18
Study 35384190 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital feedback
Number of subjects: 48
Study 35384190 — intervention group
Group type: EXPERIMENTAL
Intervention: Putty index
Number of subjects: 48
Study 35384190 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital and putty index assessment
Number of subjects: 48
Study 35384190 — intervention group
Group type: COMPARATOR
Intervention: No guide (control)
Number of subjects: 48
Study 32266765 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapy dog interaction for 5 minutes
Number of subjects: 122
Study 32266765 — intervention group
Group type: EXPERIMENTAL
Intervention: Coloring a mandala for 5 minutes
Number of subjects: 122
Study 32266765 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control)
Number of subjects: 122
Study 32266765 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapy dog interaction and coloring
Number of subjects: 122
Study 35461789 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational intervention using problematization methodology in 6 educational groups
Number of subjects: 41
Study 35461789 — intervention group
Group type: COMPARATOR
Intervention: Routine consultations (Control)
Number of subjects: 41
Study 33587394 — intervention group
Group type: EXPERIMENTAL
Intervention: Vortioxetine (10 to 20 mg/d)
Number of subjects: 41
Study 33587394 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study 33380580 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrogen inhalation (66.7% hydrogen and 33.3% oxygen, 3 L/min for 4 hours each day for 2 weeks)
Number of subjects: 20
Study 34245302 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance-based treatment (ABT)
Number of subjects: 189
Study 34245302 — intervention group
Group type: COMPARATOR
Intervention: Standard behavioral treatment (SBT)
Number of subjects: 189
Study 32278648 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulse oximeter readings under the tail
Number of subjects: 16
Study 32278648 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulse oximeter readings at the ear
Number of subjects: 16
Study 32278648 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulse oximeter readings at the cheek
Number of subjects: 16
Study 32278648 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulse oximeter readings inside the rectum
Number of subjects: 16
Study 97426120 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon (IFN) therapy
Number of subjects: 183
Study 35709811 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV 16 and 18 AS04-adjuvanted vaccine
Number of subjects: 7466
Study 35709811 — intervention group
Group type: COMPARATOR
Intervention: Hepatitis A virus vaccine (control)
Number of subjects: 7466
Study 33578191 — intervention group
Group type: EXPERIMENTAL
Intervention: Cladribine tablets 3.5 mg/kg
Number of subjects: 616
Study 33578191 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 616
Study 33166307 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal GSK2245035 20 ng once weekly for 8 weeks
Number of subjects: 36
Study 33166307 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 34111361 — intervention group
Group type: EXPERIMENTAL
Intervention: Noninvasive ventilation (NIV) in the form of bilevel positive airway pressure (BPAP) or continuous positive airway pressure (CPAP)
Number of subjects: 101
Study 34111361 — intervention group
Group type: EXPERIMENTAL
Intervention: Noninvasive ventilation (NIV)
Number of subjects: 101
Study 34491016 — intervention group
Group type: EXPERIMENTAL
Intervention: AbobotulinumtoxinA 50 U
Number of subjects: 399
Study 34491016 — intervention group
Group type: EXPERIMENTAL
Intervention: AbobotulinumtoxinA 75 U
Number of subjects: 399
Study 34491016 — intervention group
Group type: EXPERIMENTAL
Intervention: AbobotulinumtoxinA 100 U
Number of subjects: 399
Study 34491016 — intervention group
Group type: EXPERIMENTAL
Intervention: AbobotulinumtoxinA 125 U
Number of subjects: 399
Study 34491016 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 399
Study 34491016 — intervention group
Group type: EXPERIMENTAL
Intervention: AbobotulinumtoxinA (all doses)
Number of subjects: 399
Study 34501925 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral health intervention (oral health assessment, dental treatment recommendations, oral health education)
Number of subjects: 527
Study 34501925 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 527
Study 32538682 — intervention group
Group type: EXPERIMENTAL
Intervention: Transperitoneal laparoscopic radical nephroureterectomy (TLNU)
Number of subjects: 48
Study 32538682 — intervention group
Group type: COMPARATOR
Intervention: Retroperitoneal laparoscopic radical nephroureterectomy (RLNU)
Number of subjects: 48
Study 32349606 — intervention group
Group type: EXPERIMENTAL
Intervention: Transvaginal appendicectomy using innovative strategically designed submucosal tunnels
Number of subjects: 18
Study 35175218 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal gel with a bacteriophages mixture (Otofag, Micromir, Russia) twice a day for ten weeks
Number of subjects: 40
Study 35175218 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 33283986 — intervention group
Group type: EXPERIMENTAL
Intervention: Universal test and treat (UTT) intervention
Number of subjects: 144
Study 35538296 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimetazidine (TMZ) 35 mg twice daily
Number of subjects: 48
Study 35538296 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 32567065 — intervention group
Group type: EXPERIMENTAL
Intervention: WeChat WeQuit intervention (2 weeks pre- and 12 weeks post-quit)
Number of subjects: 2000
Study 32567065 — intervention group
Group type: COMPARATOR
Intervention: Control group (digital booklet of 'Happy Quit')
Number of subjects: 2000
Study 33034301 — intervention group
Group type: EXPERIMENTAL
Intervention: Intact umbilical cord milking (MUC)
Number of subjects: 144
Study 33034301 — intervention group
Group type: COMPARATOR
Intervention: Delayed cord clamping (DCC)
Number of subjects: 144
Study 34091518 — intervention group
Group type: EXPERIMENTAL
Intervention: Augmented information (education about nocebo effects)
Number of subjects: 31
Study 34091518 — intervention group
Group type: COMPARATOR
Intervention: Standard information (describing benefits and risks of TCAs)
Number of subjects: 31
Study 32543020 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolvaptan 30 mg orally daily
Number of subjects: 33
Study 32543020 — intervention group
Group type: COMPARATOR
Intervention: Furosemide 5 mg/h intravenously
Number of subjects: 33
Study 32543020 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolvaptan
Number of subjects: 33
Study 32543020 — intervention group
Group type: COMPARATOR
Intervention: Furosemide
Number of subjects: 33
Study 36171101 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous thrombolysis (IVT) before EVT
Number of subjects: 639
Study 34146033 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclopentolate 1% drop
Number of subjects: 129
Study 34146033 — intervention group
Group type: EXPERIMENTAL
Intervention: Tropicamide 0.5% drop
Number of subjects: 129
Study 34146033 — intervention group
Group type: COMPARATOR
Intervention: Comparison of both groups
Number of subjects: 129
Study 32333590 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerized cognitive training (12-week internet-based program, 40 minutes per day, 4 days a week)
Number of subjects: 260
Study 32333590 — intervention group
Group type: COMPARATOR
Intervention: Active-control group (details not specified)
Number of subjects: 260
Study 35462369 — intervention group
Group type: EXPERIMENTAL
Intervention: Desidustat oral tablets (thrice a week) for 24 weeks
Number of subjects: 392
Study 35462369 — intervention group
Group type: COMPARATOR
Intervention: Epoetin alfa subcutaneous injection for 24 weeks
Number of subjects: 392
Study 33067129 — intervention group
Group type: EXPERIMENTAL
Intervention: Fortified yogurt with 3 g HMB, 1000 IU vitamin D, and 500 mg vitamin C
Number of subjects: 66
Study 35871650 — intervention group
Group type: EXPERIMENTAL
Intervention: Time-restricted eating (TRE) for 3 weeks (daily food intake within 10 h)
Number of subjects: 14
Study 35871650 — intervention group
Group type: COMPARATOR
Intervention: Control (spreading food intake over ≥14 h)
Number of subjects: 14
Study 34700294 — intervention group
Group type: EXPERIMENTAL
Intervention: Naproxen (500 mg sodium, two capsules per day for five days)
Number of subjects: 0
Study 33590799 — intervention group
Group type: EXPERIMENTAL
Intervention: aRCT + HCQ + BEV
Number of subjects: 42
Study 33590799 — intervention group
Group type: COMPARATOR
Intervention: aRCT + BEV
Number of subjects: 42
Study 35692074 — intervention group
Group type: EXPERIMENTAL
Intervention: Bronchial thermoplasty (BT)
Number of subjects: 0
Study 35692074 — intervention group
Group type: COMPARATOR
Intervention: Sham-controlled trial (AIR2)
Number of subjects: 0
Study 33118432 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug-Coated Balloon (DCB)
Number of subjects: 120
Study 33118432 — intervention group
Group type: COMPARATOR
Intervention: Conventional Balloon (Control)
Number of subjects: 120
Study 32274653 — intervention group
Group type: COMPARATOR
Intervention: Peficitinib (20, 60, or 200 mg)
Number of subjects: 48
Study 32274653 — intervention group
Group type: COMPARATOR
Intervention: Peficitinib (10, 30, or 100 mg) twice daily for 7 days
Number of subjects: 48
Study 32274653 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 35255229 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg/day empagliflozin (EMPA)
Number of subjects: 39
Study 35255229 — intervention group
Group type: COMPARATOR
Intervention: No drug (NOEMPA)
Number of subjects: 39
Study 33343503 — intervention group
Group type: EXPERIMENTAL
Intervention: Updating training (N-back type exercises)
Number of subjects: 90
Study 33343503 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhibition training (Stroop-like exercises)
Number of subjects: 90
Study 33343503 — intervention group
Group type: COMPARATOR
Intervention: Active control (general knowledge quiz game)
Number of subjects: 90
Study 34275586 — intervention group
Group type: EXPERIMENTAL
Intervention: Apatinib (500 mg/day) and Temozolomide (50 mg/m2/day)
Number of subjects: 18
Study 33375932 — intervention group
Group type: EXPERIMENTAL
Intervention: Modulation of host thromboinflammatory response
Number of subjects: 0
Study 33375932 — intervention group
Group type: COMPARATOR
Intervention: Not available
Number of subjects: 0
Study 35199237 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-dialysis exercise program (n = 36)
Number of subjects: 71
Study 35199237 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based exercise program (n = 35)
Number of subjects: 71
Study 33515019 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Number of subjects: 508
Study 33515019 — intervention group
Group type: COMPARATOR
Intervention: Standard chemoradiation
Number of subjects: 508
Study 32087182 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate mouth rinse
Number of subjects: 50
Study 32087182 — intervention group
Group type: COMPARATOR
Intervention: Placebo control
Number of subjects: 50
Study 35405469 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimethoprim-sulfamethoxazole (TMP-SMX)
Number of subjects: 427
Study 35405469 — intervention group
Group type: EXPERIMENTAL
Intervention: Recurrent UTI
Number of subjects: 427
Study 35405469 — intervention group
Group type: EXPERIMENTAL
Intervention: Genitourinary abnormalities
Number of subjects: 427
Study 35405469 — intervention group
Group type: EXPERIMENTAL
Intervention: TMP-SMX use within 90 days
Number of subjects: 427
Study 35405469 — intervention group
Group type: COMPARATOR
Intervention: ED population
Number of subjects: 427
Study 33626144 — intervention group
Group type: EXPERIMENTAL
Intervention: Foam Rolling Group (FRG)
Number of subjects: 60
Study 33626144 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 60
Study 32693177 — intervention group
Group type: EXPERIMENTAL
Intervention: PiHQ (Partners in Helping You Quit) program
Number of subjects: 106
Study 32693177 — intervention group
Group type: COMPARATOR
Intervention: QL (Massachusetts Quitline) program
Number of subjects: 106
Study 34487566 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-energy CO2 laser treatment
Number of subjects: 20
Study 34487566 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 20
Study 34246887 — intervention group
Group type: EXPERIMENTAL
Intervention: Intense physical exercise (cycling at 80% of maximum heart rate) prior to exposures
Number of subjects: 60
Study 34246887 — intervention group
Group type: COMPARATOR
Intervention: No intense physical exercise prior to exposures (control group)
Number of subjects: 60
Study 34427492 — intervention group
Group type: EXPERIMENTAL
Intervention: Vocational interventions focusing on interpersonal functioning, emptiness, and identity disturbance.
Number of subjects: 112
Study 34427492 — intervention group
Group type: COMPARATOR
Intervention: Not applicable (control group not specified).
Number of subjects: 112
Study 34653287 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferric carboxymaltose (FCM) - two 15 mg/kg infusions 7 days apart; maximum dose, 750 mg single/1500 mg total
Number of subjects: 244
Study 34653287 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferric carboxymaltose (FCM)
Number of subjects: 244
Study 34653287 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 244
Study 35085264 — intervention group
Group type: EXPERIMENTAL
Intervention: Community beliefs and attitudes
Number of subjects: 0
Study 35085264 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulations of community beliefs and attitudes
Number of subjects: 0
Study 32771321 — intervention group
Group type: EXPERIMENTAL
Intervention: Removal of both oxygen sources
Number of subjects: 42
Study 32771321 — intervention group
Group type: EXPERIMENTAL
Intervention: Removal of non–rebreather mask with nasal cannula left in place
Number of subjects: 42
Study 35708895 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram based on cumulative anthracycline dose, ejection fractions, NT-proBNP, and diastolic dysfunction.
Number of subjects: 796
Study 35708895 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram evaluation using Hosmer-Lemeshow test.
Number of subjects: 796
Study 35708895 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram clinical utility assessed by decision curve analysis (DCA).
Number of subjects: 796
Study 35582891 — intervention group
Group type: EXPERIMENTAL
Intervention: Provider education regarding blood glucose flowsheet orders
Number of subjects: 7052
Study 35582891 — intervention group
Group type: EXPERIMENTAL
Intervention: Reminder interventions emphasizing accountability to the provider
Number of subjects: 7052
Study 35582891 — intervention group
Group type: EXPERIMENTAL
Intervention: Provider education and reminder interventions
Number of subjects: 7052
Study 32737585 — intervention group
Group type: EXPERIMENTAL
Intervention: 7.5% CO2 inhalation
Number of subjects: 22
Study 32737585 — intervention group
Group type: COMPARATOR
Intervention: Medical air (placebo) inhalation
Number of subjects: 22
Study 32774636 — intervention group
Group type: EXPERIMENTAL
Intervention: Street children
Number of subjects: 0
Study 32774636 — intervention group
Group type: COMPARATOR
Intervention: Private secondary school students (PSSS)
Number of subjects: 0
Study 35020572 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypnosis intervention
Number of subjects: 0
Study 35020572 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief hypnosis intervention via audio recording
Number of subjects: 0
Study 34915981 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 29
Study 34915981 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study 34787005 — intervention group
Group type: EXPERIMENTAL
Intervention: Ofatumumab 20 mg
Number of subjects: 64
Study 34787005 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study 34847676 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous tibial nerve stimulation (TTNS) daily for 3 months
Number of subjects: 60
Study 34847676 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous tibial nerve stimulation (PTNS) weekly for 3 months
Number of subjects: 60
Study 34396816 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical application of 100% lavender essential oil
Number of subjects: 90
Study 34396816 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaler application of 100% lavender essential oil
Number of subjects: 90
Study 34396816 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 90
Study 33359435 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic radiofrequency ablation (RFA) plus plastic stent placement
Number of subjects: 174
Study 33359435 — intervention group
Group type: COMPARATOR
Intervention: Plastic stent placement alone
Number of subjects: 174
Study 32820861 — intervention group
Group type: EXPERIMENTAL
Intervention: Proposed biosimilar filgrastim
Number of subjects: 23
Study 32820861 — intervention group
Group type: COMPARATOR
Intervention: Innovator filgrastim
Number of subjects: 23